Researchers evaluated whether toosendanin could enhance the efficacy of paclitaxel, a common chemotherapeutic agent, against TNBC.
[Advanced Biology]
Home Newsletters Mammary Cell News Synergistic Anti-Tumor Effect of Toosendanin and Paclitaxel on Triple-Negative Breast Cancer via...
